[1]
|
Kearny, P.M., Whelton, M., Reynolds, K., Muntner, P., Whelton, P.K. and He, J. (2005) Global Burden of Hypertension: Analysis of Worldwide Data. Lancet, 365, 217-223. http://dx.doi.org/10.1016/S0140-6736(05)17741-1
|
[2]
|
World Health Organization (2013) A Global Brief on Hypertension; Silent Killer, Global Public Health Crisis. World Health Organization, Geneva.
|
[3]
|
Ekwunife, O.I., Udeogaranya, P.O. and Nwatu, I.L. (2010) Prevalence, Awareness, Treatment and Control of Hypertension in a Nigerian population. Health, 2, 731-735. http://dx.doi.org/10.4236/health.2010.27111
|
[4]
|
Erhun, W.O., Olayiwola, G., Agbani, E.O. and Omotosho, N.S. (2005) Prevalence of Hypertension in a University Community in South West Nigeria. African Journal of Microbiology Research, 8, 15-19.
|
[5]
|
Neal, B., MacMahon, S. and Chapman, N. (2000) The Blood Pressure Lowering Treatment Trialists Collaboration. Effects of ACE Inhibitors, Calcium Antagonists, and Other Blood-Pressure-Lowering Drugs: Results of Prospectively designed Overview of Randomized Trials. Lancet, 355, 1955-1964.
|
[6]
|
Amira, C.O. and Okubadejo, N.U. (2006) Antihypertensive Pharmacotherapy in a Developing Economy: Pattern, Acquisition Costs and Conformity to International Guidelines in a Tertiary-Care Setting. Journal of Human Hypertension, 20, 894-897. http://dx.doi.org/10.1038/sj.jhh.1002080
|
[7]
|
Zheng, B., Poulose, A.F. and Holbrook, A. (2012) A Pilot Study on Cost-Related Medication Non Adherence in Ontario. Journal of Population Therapeutics and Clinical Pharmacology, 19, 239-47.
|
[8]
|
Ilesanmi, O.S., Ige, O.K. and Adebiyi, A.O. (2012) The Managed Hypertensive: The Cost of Blood Pressure Control in a Nigerian Town. The Pan African Medical Journal, 12, 96.
|
[9]
|
Obikeze, O.O., Ige, O.K., Osungbade, K.O., Olumide, E.A. and Asuzu, M.C. (2010) An Overview of the National Health Insurance Scheme in Nigeria. Dokita, 1, 15-21.
|
[10]
|
Liu, P.-H. and Wang, J.-D. (2008) Antihypertensive Medication Prescription Patterns and Time Trends for Newly Diagnosed Uncomplicated Hypertension Patients in Taiwan. BMC Health Services Research, 8.
|
[11]
|
US Department of Health and Human Services, National Institutes of Health, National Heart LaBI (2003) The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. NIH Report No. 03-5233.
|
[12]
|
Hall, S.H. (2006) A User’s Guide to Selecting a Comorbidity Index for Clinical Research. Journal of Clinical Epidemiology, 59, 849-855. http://dx.doi.org/10.1016/j.jclinepi.2005.11.013
|
[13]
|
Hogerzeil, H.V., Ross-Degnam, D., Laing, R.O., Ofori, A., Santoso, B., Azad, C.A.K., et al. (1993) Field Tests for Rational Drug Use in Developing Countries. Lancet, 324, 1408-1410. http://dx.doi.org/10.1016/0140-6736(93)92760-Q
|
[14]
|
Adebisi, S.A., Oghagbon, E.K. and Jimoh, A.K. (2003) Glycated Haemoglobin and Associated Variables in Diabetics: Ilorin Experience. West African Journal of Medicine, 22, 318-320.
|
[15]
|
Odili, V.U., Oghagbon, E.K., Ugwa, N.A., Ochei, U.M. and Aghomo, O.E. (2008) Adherence to International Guidelines in the Management of Hypertension in a Tertiary Hospital in Nigeria. Tropical Journal of Phatmaceutical Research, 7, 945-952. http://dx.doi.org/10.4314/tjpr.v7i2.14608
|
[16]
|
Ma, J., Lee, K. and Stafford, R.S. (2006) Changes in Antihypertensive Prescribing during US Outpatient Visits for Uncomplicated Hypertension between 1993 and 2004. Hypertension, 48, 846-852. http://dx.doi.org/10.1161/01.HYP.0000240931.90917.0c
|
[17]
|
Adigun, A.Q., Ishola, D.A., Akintomide, A.O. and Ajayi, A.A. (2003) Shifting Trends in the Pharmacological Treatment of Hypertension in a Nigerian Tertiary Hospital: A Real World Evaluation of the Efficacy, Safety, Rationality and Pharmacoeconomics of Old and New Antihypertensive Drugs. Journal of Human Hypertension, 17, 277-285. http://dx.doi.org/10.1038/sj.jhh.1001538
|